XML 37 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Information
 9 Months Ended
Sep. 29, 2023
Segment Reporting [Abstract]  
Segment Information SEGMENT INFORMATION The Company operates and reports its results in two separate business segments, the Specialty Products & Technologies and Equipment & Consumables segments. When determining the reportable segments, the Company aggregated operating segments based on their similar economic and operating characteristics. Operating profit represents total revenues less operating expenses, excluding nonoperating income (expense), interest expense and income taxes. Operating profit amounts in the Other segment consist of unallocated corporate costs and other costs not considered part of management’s evaluation of reportable segment operating performance. The identifiable assets by segment are those used in each segment’s operations. Inter-segment amounts are not significant and are eliminated to arrive at consolidated totals.
The Company’s Specialty Products & Technologies products primarily include implants, regenerative products, prosthetics, orthodontic brackets, aligners and lab products. The Company’s Equipment & Consumables products primarily include traditional consumables such as bonding agents and cements, impression materials, infection prevention products and restorative products, while the Company’s equipment products primarily include digital imaging systems, software and other visualization and magnification systems.

On December 31, 2021, the Company sold substantially all of its KaVo Treatment Unit and Instrument Business, which was part of the Company’s Equipment & Consumables segment. As a result, the financial results of the KaVo Treatment Unit and Instrument Business for the three and nine months ended September 30, 2022, were reported as discontinued operations and all segment information and descriptions exclude the KaVo Treatment Unit and Instrument Business. As of December 31, 2022, all activities related to the sale of the KaVo Treatment Unit and Instrument Business were completed and therefore there are no discontinued operations reported for the three and nine months ended September 29, 2023. Refer to Note 3 for more information on the Company’s discontinued operations.

Segment related information is shown below ($ in millions):
Three Months EndedNine Months Ended
September 29, 2023September 30, 2022September 29, 2023September 30, 2022
Sales:
Specialty Products & Technologies$399.5 $395.4 $1,226.5 $1,200.2 
Equipment & Consumables231.8 235.7 694.4 708.1 
Total$631.3 $631.1 $1,920.9 $1,908.3 
Operating profit and reconciliation to income before taxes from continuing operations:
Specialty Products & Technologies$61.4 $62.3 $188.2 $206.6 
Equipment & Consumables43.9 44.7 124.8 120.4 
Other(22.0)(32.5)(78.7)(95.8)
Operating profit83.3 74.5 234.3 231.2 
Nonoperating income (expense):
   Other (expense) income(32.1)0.3 (24.7)0.9 
   Interest expense, net(15.4)(11.6)(49.5)(23.9)
Income before taxes from continuing operations$35.8 $63.2 $160.1 $208.2 
Identifiable assets:September 29, 2023December 31, 2022
Specialty Products & Technologies$3,384.5 $3,475.7 
Equipment & Consumables2,428.4 2,455.3 
Other870.9 656.0 
Total$6,683.8 $6,587.0